Determinants of variable response to GLP-1 receptor agonists: A mechanism-informed framework for precision treatment of obesity
Author:
Open Access
- 7 October 2026
- journal article
- Published by Elsevier in Obesity Pillars
- Vol. 20
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- A GLP1R gene variant and sex influence the response to semaglutide treatment in patients with severe obesityObesity, 2025
- Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy RegulationThe American Journal of Medicine, 2025
- Central nervous system pathways targeted by amylin in the regulation of food intakeBiochimie, 2024
- Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptorCell Metabolism, 2024
- EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)Journal of Hepatology, 2024
- Obesity: A Review of Pathophysiology and ClassificationMayo Clinic Proceedings, 2023
- Selection of antiobesity medications based on phenotypes enhances weight loss: A pragmatic trial in an obesity clinicObesity, 2021
- Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity ClinicObesity, 2021
- Battle of GLP-1 delivery technologiesAdvanced Drug Delivery Reviews, 2018
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1Cell Metabolism, 2018